SB 41 prohibits spread pricing, requires PBMs and group purchasing organizations to pass through 100% of manufacturer rebates ...

It was found that adding NB-UVB light therapy to ruxolitinib (Opzelura) 1.5% cream helped many vitiligo patients who did not respond early to treatment achieve faster and more noticeable skin ...

Insurance coverage remained historically high, though it declined slightly from its peak. In 2024, 91.8% of the population was insured, down from 92.5% in 2023. Private health insurance enrollment ...

Trastuzumab-based regimens were the primary treatment for older adults with advanced HER2-positive gastric cancer before immunotherapy became standard. The study highlights substantial economic ...

In a study of more than 31,000 adults, an EHR-integrated patient-facing tool significantly improved identification of ...

TikTok videos by physicians on mammograms scored highest in quality, highlighting the importance of professional involvement in health information dissemination. The DISCERN tool was used to evaluate ...

It was announced today that Jefferson Health, Penn Medicine and Temple Health have been selected as the 2026 Clinical Care ...

Breast cancer screening based on individual risk rather than annual screening is safe, effective and preferred by patients, ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Children’s Hospital of Philadelphia (CHOP) has partnered with Soar Autism Center to expand access to early autism care in the Philadelphia region through a new network of integrated outpatient therapy ...

In 2026, AI will continue threading itself into behavioral health, and the bar will rise sharply for what counts as ...

The study revealed that the strongest and most consistent evidence supports music-based sleep aids. Across multiple studies, listening to calming music before bedtime was linked to better sleep ...